Global Losartan Market, By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Strength (25mg, 50mg, 100mg, Others), By Distribution Channel (Offline, Online), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By End-User (Adult, Pediatric), By Region, Forecast & Opportunities, 2026
Global losartan market was valued at USD4.73 billion in 2020 and is expected to grow at a formidable rate of 7.81% during the forecast period. The global losartan market is driven by the growing prevalence of hypertension, stroke and diabetic nephropathy across the world. Losartan is a medication that is used to treat high blood pressure. Furthermore, losartan is widely used in slowing down long-term kidney damage due to type II diabetes which is further expected to propel the market growth through 2026. The sudden outbreak and spread of the COVID-19 pandemic has resulted in the loss of jobs for many people due to which the level of anxiety and hypertension has increased among the people. This has, in turn, increased the demand for losartan, thereby fueling the market growth during the forecast period. Many major biotechnology and pharmaceutical companies are working on manufacturing in-house losartan tablets which are expected to create lucrative opportunities for the market growth over the next few years.
The global losartan market is segmented based on source, form, strength, distribution channel, application, end-user, company and region. Based on source, the market can be split into contract manufacturing organizations and in-house. Among these, the in-house segment is expected to witness the fastest growth due to increased preference for in-house manufacturing by key market players as the company can have full control over the quality and the quantity of the products. Based on form, the market can be fragmented into tablets and powder. Here, the tablet segment is dominating the market with a market share of nearly 87% and is expected to maintain its position in the forecast years as well. Based on distribution channel, the market can be segmented into online and offline. The offline channel is expected to dominate the market due to surging consumer preference for purchasing medicines from a pharmacy or drug store. The online segment is also expected to register significant growth over the next few years.
Regionally, the global losartan market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate in the overall losartan market owing to the well-established healthcare infrastructure and presence of major pharmaceutical and biotechnology giants in the region. However, Asia-Pacific is expected to witness robust growth in the market owing to the presence of a large pool of patients suffering from various life-threatening conditions in economies such as China and India.
Major players operating in the global losartan market include Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis International AG, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Aurobindo Pharma Ltd., Torrent Pharmaceutical Ltd., Lupin Ltd., Mylan N.V., Ipca Laboratories Limited, Macleods Pharmaceuticals Limited, Abbott Laboratories, Cadila Healthcare Limited, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions.
Years considered for this report:
TechSci Research calculated the market size of global Losartan market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
Report Scope:
In this report, global losartan market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the global losartan market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
The global losartan market is segmented based on source, form, strength, distribution channel, application, end-user, company and region. Based on source, the market can be split into contract manufacturing organizations and in-house. Among these, the in-house segment is expected to witness the fastest growth due to increased preference for in-house manufacturing by key market players as the company can have full control over the quality and the quantity of the products. Based on form, the market can be fragmented into tablets and powder. Here, the tablet segment is dominating the market with a market share of nearly 87% and is expected to maintain its position in the forecast years as well. Based on distribution channel, the market can be segmented into online and offline. The offline channel is expected to dominate the market due to surging consumer preference for purchasing medicines from a pharmacy or drug store. The online segment is also expected to register significant growth over the next few years.
Regionally, the global losartan market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate in the overall losartan market owing to the well-established healthcare infrastructure and presence of major pharmaceutical and biotechnology giants in the region. However, Asia-Pacific is expected to witness robust growth in the market owing to the presence of a large pool of patients suffering from various life-threatening conditions in economies such as China and India.
Major players operating in the global losartan market include Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis International AG, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Aurobindo Pharma Ltd., Torrent Pharmaceutical Ltd., Lupin Ltd., Mylan N.V., Ipca Laboratories Limited, Macleods Pharmaceuticals Limited, Abbott Laboratories, Cadila Healthcare Limited, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions.
Years considered for this report:
- Historical Years: 2016-2019
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022–2026
- To analyze the historical growth in the market size of the global losartan market from 2016 to 2020.
- To estimate and forecast the market size of the global losartan market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast the global losartan market based on source, form, strength, distribution channel, application, end-user, company and regional distribution.
- To identify dominant region or segment in the global losartan market.
- To identify drivers and challenges for global losartan market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global losartan market.
- To identify and analyze the profile of leading players operating in global losartan market.
- To identify key sustainable strategies adopted by market players in global losartan market.
TechSci Research calculated the market size of global Losartan market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Losartan manufacturers, suppliers, distributors and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to losartan kit
- Market research and consulting firms
Report Scope:
In this report, global losartan market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Global Losartan Market, By Source:
- Contract Manufacturing Organizations
- In-House
- Global Losartan Market, By Form:
- Tablet
- Powder
- Global Losartan Market, By Strength:
- 25 mg
- 50 mg
- 100 mg
- Others
- Global Losartan Market, By Distribution Channel:
- Offline
- Online
- Global Losartan Market, By Application:
- Hypertension
- Stroke
- Diabetic nephropathy
- Others
- Global Losartan Market, By End-User:
- Adult
- Pediatric
- Global Losartan Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Poland
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Hong Kong
- Philippines
- Malaysia
- Indonesia
- Vietnam
- Thailand
- South America
- Brazil
- Argentina
- Colombia
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Nigeria
- Kenya
- Algeria
- Ethiopia
Company Profiles: Detailed analysis of the major companies present in the global losartan market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL LOSARTAN MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. GLOBAL LOSARTAN MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Source (Contract Manufacturing Organizations, In-House)
6.2.2. By Form (Tablet, Powder)
6.2.3. By Strength (25 mg, 50 mg, 100 mg, Others)
6.2.4. By Distribution Channel (Offline, Online)
6.2.5. By Application (Hypertension, Stroke, Diabetic nephropathy, Others)
6.2.6. By End-User (Adult, Pediatric)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Product Market Map
7. NORTH AMERICA LOSARTAN MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Source
7.2.2. By Form
7.2.3. By Strength
7.2.4. By Distribution Channel
7.2.5. By Application
7.2.6. By End-User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Losartan Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Source
7.3.1.2.2. By Form
7.3.1.2.3. By Strength
7.3.1.2.4. By Distribution Channel
7.3.1.2.5. By Application
7.3.1.2.6. By End-User
7.3.2. Canada Losartan Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Source
7.3.2.2.2. By Form
7.3.2.2.3. By Strength
7.3.2.2.4. By Distribution Channel
7.3.2.2.5. By Application
7.3.2.2.6. By End-User
7.3.3. Mexico Losartan Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Source
7.3.3.2.2. By Form
7.3.3.2.3. By Strength
7.3.3.2.4. By Distribution Channel
7.3.3.2.5. By Application
7.3.3.2.6. By End-User
8. EUROPE LOSARTAN MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Source
8.2.2. By Form
8.2.3. By Strength
8.2.4. By Distribution Channel
8.2.5. By Application
8.2.6. By End-User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Losartan Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Source
8.3.1.2.2. By Form
8.3.1.2.3. By Strength
8.3.1.2.4. By Distribution Channel
8.3.1.2.5. By Application
8.3.1.2.6. By End-User
8.3.2. France Losartan Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Source
8.3.2.2.2. By Form
8.3.2.2.3. By Strength
8.3.2.2.4. By Distribution Channel
8.3.2.2.5. By Application
8.3.2.2.6. By End-User
8.3.3. United Kingdom Losartan Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Source
8.3.3.2.2. By Form
8.3.3.2.3. By Strength
8.3.3.2.4. By Distribution Channel
8.3.3.2.5. By Application
8.3.3.2.6. By End-User
8.3.4. Italy Losartan Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Source
8.3.4.2.2. By Form
8.3.4.2.3. By Strength
8.3.4.2.4. By Distribution Channel
8.3.4.2.5. By Application
8.3.4.2.6. By End-User
8.3.5. Spain Losartan Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Source
8.3.5.2.2. By Form
8.3.5.2.3. By Strength
8.3.5.2.4. By Distribution Channel
8.3.5.2.5. By Application
8.3.5.2.6. By End-User
8.3.6. Russia Losartan Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Source
8.3.6.2.2. By Form
8.3.6.2.3. By Strength
8.3.6.2.4. By Distribution Channel
8.3.6.2.5. By Application
8.3.6.2.6. By End-User
8.3.7. Poland Losartan Market Outlook
8.3.7.1. Market Size & Forecast
8.3.7.1.1. By Value
8.3.7.2. Market Share & Forecast
8.3.7.2.1. By Source
8.3.7.2.2. By Form
8.3.7.2.3. By Strength
8.3.7.2.4. By Distribution Channel
8.3.7.2.5. By Application
8.3.7.2.6. By End-User
9. ASIA-PACIFIC LOSARTAN MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Source
9.2.2. By Form
9.2.3. By Strength
9.2.4. By Distribution Channel
9.2.5. By Application
9.2.6. By End-User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Losartan Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Source
9.3.1.2.2. By Form
9.3.1.2.3. By Strength
9.3.1.2.4. By Distribution Channel
9.3.1.2.5. By Application
9.3.1.2.6. By End-User
9.3.2. Japan Losartan Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Source
9.3.2.2.2. By Form
9.3.2.2.3. By Strength
9.3.2.2.4. By Distribution Channel
9.3.2.2.5. By Application
9.3.2.2.6. By End-User
9.3.3. India Losartan Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Source
9.3.3.2.2. By Form
9.3.3.2.3. By Strength
9.3.3.2.4. By Distribution Channel
9.3.3.2.5. By Application
9.3.3.2.6. By End-User
9.3.4. Australia Losartan Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Source
9.3.4.2.2. By Form
9.3.4.2.3. By Strength
9.3.4.2.4. By Distribution Channel
9.3.4.2.5. By Application
9.3.4.2.6. By End-User
9.3.5. South Korea Losartan Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Source
9.3.5.2.2. By Form
9.3.5.2.3. By Strength
9.3.5.2.4. By Distribution Channel
9.3.5.2.5. By Application
9.3.5.2.6. By End-User
9.3.6. Hong Kong Losartan Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Source
9.3.6.2.2. By Form
9.3.6.2.3. By Strength
9.3.6.2.4. By Distribution Channel
9.3.6.2.5. By Application
9.3.6.2.6. By End-User
9.3.7. Philippines Losartan Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Source
9.3.7.2.2. By Form
9.3.7.2.3. By Strength
9.3.7.2.4. By Distribution Channel
9.3.7.2.5. By Application
9.3.7.2.6. By End-User
9.3.8. Malaysia Losartan Market Outlook
9.3.8.1. Market Size & Forecast
9.3.8.1.1. By Value
9.3.8.2. Market Share & Forecast
9.3.8.2.1. By Source
9.3.8.2.2. By Form
9.3.8.2.3. By Strength
9.3.8.2.4. By Distribution Channel
9.3.8.2.5. By Application
9.3.8.2.6. By End-User
9.3.9. Indonesia Losartan Market Outlook
9.3.9.1. Market Size & Forecast
9.3.9.1.1. By Value
9.3.9.2. Market Share & Forecast
9.3.9.2.1. By Source
9.3.9.2.2. By Form
9.3.9.2.3. By Strength
9.3.9.2.4. By Distribution Channel
9.3.9.2.5. By Application
9.3.9.2.6. By End-User
9.3.10. Vietnam Losartan Market Outlook
9.3.10.1. Market Size & Forecast
9.3.10.1.1. By Value
9.3.10.2. Market Share & Forecast
9.3.10.2.1. By Source
9.3.10.2.2. By Form
9.3.10.2.3. By Strength
9.3.10.2.4. By Distribution Channel
9.3.10.2.5. By Application
9.3.10.2.6. By End-User
9.3.11. Thailand Losartan Market Outlook
9.3.11.1. Market Size & Forecast
9.3.11.1.1. By Value
9.3.11.2. Market Share & Forecast
9.3.11.2.1. By Source
9.3.11.2.2. By Form
9.3.11.2.3. By Strength
9.3.11.2.4. By Distribution Channel
9.3.11.2.5. By Application
9.3.11.2.6. By End-User
10. SOUTH AMERICA LOSARTAN MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Source
10.2.2. By Form
10.2.3. By Strength
10.2.4. By Distribution Channel
10.2.5. By Application
10.2.6. By End-User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Losartan Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Source
10.3.1.2.2. By Form
10.3.1.2.3. By Strength
10.3.1.2.4. By Distribution Channel
10.3.1.2.5. By Application
10.3.1.2.6. By End-User
10.3.2. Argentina Losartan Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Source
10.3.2.2.2. By Form
10.3.2.2.3. By Strength
10.3.2.2.4. By Distribution Channel
10.3.2.2.5. By Application
10.3.2.2.6. By End-User
10.3.3. Colombia Losartan Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Source
10.3.3.2.2. By Form
10.3.3.2.3. By Strength
10.3.3.2.4. By Distribution Channel
10.3.3.2.5. By Application
10.3.3.2.6. By End-User
10.3.4. Chile Losartan Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Source
10.3.4.2.2. By Form
10.3.4.2.3. By Strength
10.3.4.2.4. By Distribution Channel
10.3.4.2.5. By Application
10.3.4.2.6. By End-User
11. MIDDLE EAST AND AFRICA LOSARTAN MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Source
11.2.2. By Form
11.2.3. By Strength
11.2.4. By Distribution Channel
11.2.5. By Application
11.2.6. By End-User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Losartan Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Source
11.3.1.2.2. By Form
11.3.1.2.3. By Strength
11.3.1.2.4. By Distribution Channel
11.3.1.2.5. By Application
11.3.1.2.6. By End-User
11.3.2. Saudi Arabia Losartan Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Source
11.3.2.2.2. By Form
11.3.2.2.3. By Strength
11.3.2.2.4. By Distribution Channel
11.3.2.2.5. By Application
11.3.2.2.6. By End-User
11.3.3. UAE Losartan Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Source
11.3.3.2.2. By Form
11.3.3.2.3. By Strength
11.3.3.2.4. By Distribution Channel
11.3.3.2.5. By Application
11.3.3.2.6. By End-User
11.3.4. Turkey Losartan Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Source
11.3.4.2.2. By Form
11.3.4.2.3. By Strength
11.3.4.2.4. By Distribution Channel
11.3.4.2.5. By Application
11.3.4.2.6. By End-User
11.3.5. Nigeria Losartan Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Source
11.3.5.2.2. By Form
11.3.5.2.3. By Strength
11.3.5.2.4. By Distribution Channel
11.3.5.2.5. By Application
11.3.5.2.6. By End-User
11.3.6. Kenya Losartan Market Outlook
11.3.6.1. Market Size & Forecast
11.3.6.1.1. By Value
11.3.6.2. Market Share & Forecast
11.3.6.2.1. By Source
11.3.6.2.2. By Form
11.3.6.2.3. By Strength
11.3.6.2.4. By Distribution Channel
11.3.6.2.5. By Application
11.3.6.2.6. By End-User
11.3.7. Algeria Losartan Market Outlook
11.3.7.1. Market Size & Forecast
11.3.7.1.1. By Value
11.3.7.2. Market Share & Forecast
11.3.7.2.1. By Source
11.3.7.2.2. By Form
11.3.7.2.3. By Strength
11.3.7.2.4. By Distribution Channel
11.3.7.2.5. By Application
11.3.7.2.6. By End-User
11.3.8. Ethiopia Losartan Market Outlook
11.3.8.1. Market Size & Forecast
11.3.8.1.1. By Value
11.3.8.2. Market Share & Forecast
11.3.8.2.1. By Source
11.3.8.2.2. By Form
11.3.8.2.3. By Strength
11.3.8.2.4. By Distribution Channel
11.3.8.2.5. By Application
11.3.8.2.6. By End-User
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Merck & Co. Inc.
14.2. Pfizer Inc.
14.3. Teva Pharmaceutical Industries Ltd.
14.4. Sanofi S.A.
14.5. Novartis International AG
14.6. Dr. Reddy’s Laboratories Ltd.
14.7. Sun Pharmaceuticals Industries Ltd.
14.8. Aurobindo Pharma Ltd.
14.9. Torrent Pharmaceutical Ltd.
14.10. Lupin Ltd.
14.11. Mylan N.V.
14.12. Ipca Laboratories Limited
14.13. Macleods Pharmaceuticals Limited
14.14. Abbott Laboratories
14.15. Cadila Healthcare Limited
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL LOSARTAN MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. GLOBAL LOSARTAN MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Source (Contract Manufacturing Organizations, In-House)
6.2.2. By Form (Tablet, Powder)
6.2.3. By Strength (25 mg, 50 mg, 100 mg, Others)
6.2.4. By Distribution Channel (Offline, Online)
6.2.5. By Application (Hypertension, Stroke, Diabetic nephropathy, Others)
6.2.6. By End-User (Adult, Pediatric)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Product Market Map
7. NORTH AMERICA LOSARTAN MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Source
7.2.2. By Form
7.2.3. By Strength
7.2.4. By Distribution Channel
7.2.5. By Application
7.2.6. By End-User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Losartan Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Source
7.3.1.2.2. By Form
7.3.1.2.3. By Strength
7.3.1.2.4. By Distribution Channel
7.3.1.2.5. By Application
7.3.1.2.6. By End-User
7.3.2. Canada Losartan Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Source
7.3.2.2.2. By Form
7.3.2.2.3. By Strength
7.3.2.2.4. By Distribution Channel
7.3.2.2.5. By Application
7.3.2.2.6. By End-User
7.3.3. Mexico Losartan Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Source
7.3.3.2.2. By Form
7.3.3.2.3. By Strength
7.3.3.2.4. By Distribution Channel
7.3.3.2.5. By Application
7.3.3.2.6. By End-User
8. EUROPE LOSARTAN MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Source
8.2.2. By Form
8.2.3. By Strength
8.2.4. By Distribution Channel
8.2.5. By Application
8.2.6. By End-User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Losartan Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Source
8.3.1.2.2. By Form
8.3.1.2.3. By Strength
8.3.1.2.4. By Distribution Channel
8.3.1.2.5. By Application
8.3.1.2.6. By End-User
8.3.2. France Losartan Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Source
8.3.2.2.2. By Form
8.3.2.2.3. By Strength
8.3.2.2.4. By Distribution Channel
8.3.2.2.5. By Application
8.3.2.2.6. By End-User
8.3.3. United Kingdom Losartan Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Source
8.3.3.2.2. By Form
8.3.3.2.3. By Strength
8.3.3.2.4. By Distribution Channel
8.3.3.2.5. By Application
8.3.3.2.6. By End-User
8.3.4. Italy Losartan Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Source
8.3.4.2.2. By Form
8.3.4.2.3. By Strength
8.3.4.2.4. By Distribution Channel
8.3.4.2.5. By Application
8.3.4.2.6. By End-User
8.3.5. Spain Losartan Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Source
8.3.5.2.2. By Form
8.3.5.2.3. By Strength
8.3.5.2.4. By Distribution Channel
8.3.5.2.5. By Application
8.3.5.2.6. By End-User
8.3.6. Russia Losartan Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Source
8.3.6.2.2. By Form
8.3.6.2.3. By Strength
8.3.6.2.4. By Distribution Channel
8.3.6.2.5. By Application
8.3.6.2.6. By End-User
8.3.7. Poland Losartan Market Outlook
8.3.7.1. Market Size & Forecast
8.3.7.1.1. By Value
8.3.7.2. Market Share & Forecast
8.3.7.2.1. By Source
8.3.7.2.2. By Form
8.3.7.2.3. By Strength
8.3.7.2.4. By Distribution Channel
8.3.7.2.5. By Application
8.3.7.2.6. By End-User
9. ASIA-PACIFIC LOSARTAN MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Source
9.2.2. By Form
9.2.3. By Strength
9.2.4. By Distribution Channel
9.2.5. By Application
9.2.6. By End-User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Losartan Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Source
9.3.1.2.2. By Form
9.3.1.2.3. By Strength
9.3.1.2.4. By Distribution Channel
9.3.1.2.5. By Application
9.3.1.2.6. By End-User
9.3.2. Japan Losartan Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Source
9.3.2.2.2. By Form
9.3.2.2.3. By Strength
9.3.2.2.4. By Distribution Channel
9.3.2.2.5. By Application
9.3.2.2.6. By End-User
9.3.3. India Losartan Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Source
9.3.3.2.2. By Form
9.3.3.2.3. By Strength
9.3.3.2.4. By Distribution Channel
9.3.3.2.5. By Application
9.3.3.2.6. By End-User
9.3.4. Australia Losartan Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Source
9.3.4.2.2. By Form
9.3.4.2.3. By Strength
9.3.4.2.4. By Distribution Channel
9.3.4.2.5. By Application
9.3.4.2.6. By End-User
9.3.5. South Korea Losartan Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Source
9.3.5.2.2. By Form
9.3.5.2.3. By Strength
9.3.5.2.4. By Distribution Channel
9.3.5.2.5. By Application
9.3.5.2.6. By End-User
9.3.6. Hong Kong Losartan Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Source
9.3.6.2.2. By Form
9.3.6.2.3. By Strength
9.3.6.2.4. By Distribution Channel
9.3.6.2.5. By Application
9.3.6.2.6. By End-User
9.3.7. Philippines Losartan Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Source
9.3.7.2.2. By Form
9.3.7.2.3. By Strength
9.3.7.2.4. By Distribution Channel
9.3.7.2.5. By Application
9.3.7.2.6. By End-User
9.3.8. Malaysia Losartan Market Outlook
9.3.8.1. Market Size & Forecast
9.3.8.1.1. By Value
9.3.8.2. Market Share & Forecast
9.3.8.2.1. By Source
9.3.8.2.2. By Form
9.3.8.2.3. By Strength
9.3.8.2.4. By Distribution Channel
9.3.8.2.5. By Application
9.3.8.2.6. By End-User
9.3.9. Indonesia Losartan Market Outlook
9.3.9.1. Market Size & Forecast
9.3.9.1.1. By Value
9.3.9.2. Market Share & Forecast
9.3.9.2.1. By Source
9.3.9.2.2. By Form
9.3.9.2.3. By Strength
9.3.9.2.4. By Distribution Channel
9.3.9.2.5. By Application
9.3.9.2.6. By End-User
9.3.10. Vietnam Losartan Market Outlook
9.3.10.1. Market Size & Forecast
9.3.10.1.1. By Value
9.3.10.2. Market Share & Forecast
9.3.10.2.1. By Source
9.3.10.2.2. By Form
9.3.10.2.3. By Strength
9.3.10.2.4. By Distribution Channel
9.3.10.2.5. By Application
9.3.10.2.6. By End-User
9.3.11. Thailand Losartan Market Outlook
9.3.11.1. Market Size & Forecast
9.3.11.1.1. By Value
9.3.11.2. Market Share & Forecast
9.3.11.2.1. By Source
9.3.11.2.2. By Form
9.3.11.2.3. By Strength
9.3.11.2.4. By Distribution Channel
9.3.11.2.5. By Application
9.3.11.2.6. By End-User
10. SOUTH AMERICA LOSARTAN MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Source
10.2.2. By Form
10.2.3. By Strength
10.2.4. By Distribution Channel
10.2.5. By Application
10.2.6. By End-User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Losartan Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Source
10.3.1.2.2. By Form
10.3.1.2.3. By Strength
10.3.1.2.4. By Distribution Channel
10.3.1.2.5. By Application
10.3.1.2.6. By End-User
10.3.2. Argentina Losartan Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Source
10.3.2.2.2. By Form
10.3.2.2.3. By Strength
10.3.2.2.4. By Distribution Channel
10.3.2.2.5. By Application
10.3.2.2.6. By End-User
10.3.3. Colombia Losartan Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Source
10.3.3.2.2. By Form
10.3.3.2.3. By Strength
10.3.3.2.4. By Distribution Channel
10.3.3.2.5. By Application
10.3.3.2.6. By End-User
10.3.4. Chile Losartan Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Source
10.3.4.2.2. By Form
10.3.4.2.3. By Strength
10.3.4.2.4. By Distribution Channel
10.3.4.2.5. By Application
10.3.4.2.6. By End-User
11. MIDDLE EAST AND AFRICA LOSARTAN MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Source
11.2.2. By Form
11.2.3. By Strength
11.2.4. By Distribution Channel
11.2.5. By Application
11.2.6. By End-User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Losartan Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Source
11.3.1.2.2. By Form
11.3.1.2.3. By Strength
11.3.1.2.4. By Distribution Channel
11.3.1.2.5. By Application
11.3.1.2.6. By End-User
11.3.2. Saudi Arabia Losartan Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Source
11.3.2.2.2. By Form
11.3.2.2.3. By Strength
11.3.2.2.4. By Distribution Channel
11.3.2.2.5. By Application
11.3.2.2.6. By End-User
11.3.3. UAE Losartan Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Source
11.3.3.2.2. By Form
11.3.3.2.3. By Strength
11.3.3.2.4. By Distribution Channel
11.3.3.2.5. By Application
11.3.3.2.6. By End-User
11.3.4. Turkey Losartan Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Source
11.3.4.2.2. By Form
11.3.4.2.3. By Strength
11.3.4.2.4. By Distribution Channel
11.3.4.2.5. By Application
11.3.4.2.6. By End-User
11.3.5. Nigeria Losartan Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Source
11.3.5.2.2. By Form
11.3.5.2.3. By Strength
11.3.5.2.4. By Distribution Channel
11.3.5.2.5. By Application
11.3.5.2.6. By End-User
11.3.6. Kenya Losartan Market Outlook
11.3.6.1. Market Size & Forecast
11.3.6.1.1. By Value
11.3.6.2. Market Share & Forecast
11.3.6.2.1. By Source
11.3.6.2.2. By Form
11.3.6.2.3. By Strength
11.3.6.2.4. By Distribution Channel
11.3.6.2.5. By Application
11.3.6.2.6. By End-User
11.3.7. Algeria Losartan Market Outlook
11.3.7.1. Market Size & Forecast
11.3.7.1.1. By Value
11.3.7.2. Market Share & Forecast
11.3.7.2.1. By Source
11.3.7.2.2. By Form
11.3.7.2.3. By Strength
11.3.7.2.4. By Distribution Channel
11.3.7.2.5. By Application
11.3.7.2.6. By End-User
11.3.8. Ethiopia Losartan Market Outlook
11.3.8.1. Market Size & Forecast
11.3.8.1.1. By Value
11.3.8.2. Market Share & Forecast
11.3.8.2.1. By Source
11.3.8.2.2. By Form
11.3.8.2.3. By Strength
11.3.8.2.4. By Distribution Channel
11.3.8.2.5. By Application
11.3.8.2.6. By End-User
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Merck & Co. Inc.
14.2. Pfizer Inc.
14.3. Teva Pharmaceutical Industries Ltd.
14.4. Sanofi S.A.
14.5. Novartis International AG
14.6. Dr. Reddy’s Laboratories Ltd.
14.7. Sun Pharmaceuticals Industries Ltd.
14.8. Aurobindo Pharma Ltd.
14.9. Torrent Pharmaceutical Ltd.
14.10. Lupin Ltd.
14.11. Mylan N.V.
14.12. Ipca Laboratories Limited
14.13. Macleods Pharmaceuticals Limited
14.14. Abbott Laboratories
14.15. Cadila Healthcare Limited
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
LIST OF FIGURES
Figure 1: Global Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Losartan Market Size, By Volume (USD Billion), 2016-2026F
Figure 3: Global Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 4: Global Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 5: Global Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 6: Global Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 7: Global Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 8: Global Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 9: Global Losartan Market Share, By Region (USD Billion), 2016-2026F
Figure 10: Global Losartan Market Share, By Company (USD Billion), 2016-2026F
Figure 11: Global Losartan Market Attractiveness Index, By Region, By Value, 2016-2026F
Figure 12: Global Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 13: North America Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 14: North America Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 15: North America Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 16: North America Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 17: North America Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 18: North America Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 19: North America Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 20: North America Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 21: North America Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 22: North America Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 23: United States Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 24: United States Losartan Market Size, By Source, 2016-2026F
Figure 25: United States Losartan Market Size, By Form, 2016-2026F
Figure 26: United States Losartan Market Size, By Strength, 2016-2026F
Figure 27: United States Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 28: United States Losartan Market Share, By Application, 2016-2026F
Figure 29: United States Losartan Market Share, By End-User, 2016-2026F
Figure 30: Canada Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 31: Canada Losartan Market Size, By Source, 2016-2026F
Figure 32: Canada Losartan Market Size, By Form, 2016-2026F
Figure 33: Canada Losartan Market Size, By Strength, 2016-2026F
Figure 34: Canada Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 35: Canada Losartan Market Share, By Application, 2016-2026F
Figure 36: Canada Losartan Market Share, By End-User, 2016-2026F
Figure 37: Mexico Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 38: Mexico Losartan Market Size, By Source, 2016-2026F
Figure 39: Mexico Losartan Market Size, By Form, 2016-2026F
Figure 40: Mexico Losartan Market Size, By Strength, 2016-2026F
Figure 41: Mexico Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 42: Mexico Losartan Market Share, By Application, 2016-2026F
Figure 43: Mexico Losartan Market Share, By End-User, 2016-2026F
Figure 44: Europe Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 45: Europe Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 46: Europe Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 47: Europe Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 48: Europe Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 49: Europe Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 50: Europe Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 51: Europe Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 52: Europe Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 53: Europe Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 54: Germany Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 55: Germany Losartan Market Size, By Source, 2016-2026F
Figure 56: Germany Losartan Market Size, By Form, 2016-2026F
Figure 57: Germany Losartan Market Size, By Strength, 2016-2026F
Figure 58: Germany Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 59: Germany Losartan Market Share, By Application, 2016-2026F
Figure 60: Germany Losartan Market Share, By End-User, 2016-2026F
Figure 61: France Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 62: France Losartan Market Size, By Source, 2016-2026F
Figure 63: France Losartan Market Size, By Form, 2016-2026F
Figure 64: France Losartan Market Size, By Strength, 2016-2026F
Figure 65: France Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 66: France Losartan Market Share, By Application, 2016-2026F
Figure 67: France Losartan Market Share, By End-User, 2016-2026F
Figure 68: United Kingdom Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 69: United Kingdom Losartan Market Size, By Source, 2016-2026F
Figure 70: United Kingdom Losartan Market Size, By Form, 2016-2026F
Figure 71: United Kingdom Losartan Market Size, By Strength, 2016-2026F
Figure 72: United Kingdom Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 73: United Kingdom Losartan Market Share, By Application, 2016-2026F
Figure 74: United Kingdom Losartan Market Share, By End-User, 2016-2026F
Figure 75: Italy Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 76: Italy Losartan Market Size, By Source, 2016-2026F
Figure 77: Italy Losartan Market Size, By Form, 2016-2026F
Figure 78: Italy Losartan Market Size, By Strength, 2016-2026F
Figure 79: Italy Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 80: Italy Losartan Market Share, By Application, 2016-2026F
Figure 81: Italy Losartan Market Share, By End-User, 2016-2026F
Figure 82: Spain Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 83: Spain Losartan Market Size, By Source, 2016-2026F
Figure 84: Spain Losartan Market Size, By Form, 2016-2026F
Figure 85: Spain Losartan Market Size, By Strength, 2016-2026F
Figure 86: Spain Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 87: Spain Losartan Market Share, By Application, 2016-2026F
Figure 88: Spain Losartan Market Share, By End-User, 2016-2026F
Figure 89: Russia Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 90: Russia Losartan Market Size, By Source, 2016-2026F
Figure 91: Russia Losartan Market Size, By Form, 2016-2026F
Figure 92: Russia Losartan Market Size, By Strength, 2016-2026F
Figure 93: Russia Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 94: Russia Losartan Market Share, By Application, 2016-2026F
Figure 95: Russia Losartan Market Share, By End-User, 2016-2026F
Figure 96: Poland Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 97: Poland Losartan Market Size, By Source, 2016-2026F
Figure 98: Poland Losartan Market Size, By Form, 2016-2026F
Figure 99: Poland Losartan Market Size, By Strength, 2016-2026F
Figure 100: Poland Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 101: Poland Losartan Market Share, By Application, 2016-2026F
Figure 102: Poland Losartan Market Share, By End-User, 2016-2026F
Figure 103: Asia-Pacific Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 104: Asia-Pacific Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 105: Asia-Pacific Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 106: Asia-Pacific Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 107: Asia-Pacific Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 108: Asia-Pacific Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 109: Asia-Pacific Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 110: Asia-Pacific Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 111: Asia-Pacific Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 112: Asia-Pacific Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 113: China Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 114: China Losartan Market Size, By Source, 2016-2026F
Figure 115: China Losartan Market Size, By Form, 2016-2026F
Figure 116: China Losartan Market Size, By Strength, 2016-2026F
Figure 117: China Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 118: China Losartan Market Share, By Application, 2016-2026F
Figure 119: China Losartan Market Share, By End-User, 2016-2026F
Figure 120: Japan Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 121: Japan Losartan Market Size, By Source, 2016-2026F
Figure 122: Japan Losartan Market Size, By Form, 2016-2026F
Figure 123: Japan Losartan Market Size, By Strength, 2016-2026F
Figure 124: Japan Losart
Figure 1: Global Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Losartan Market Size, By Volume (USD Billion), 2016-2026F
Figure 3: Global Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 4: Global Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 5: Global Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 6: Global Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 7: Global Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 8: Global Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 9: Global Losartan Market Share, By Region (USD Billion), 2016-2026F
Figure 10: Global Losartan Market Share, By Company (USD Billion), 2016-2026F
Figure 11: Global Losartan Market Attractiveness Index, By Region, By Value, 2016-2026F
Figure 12: Global Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 13: North America Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 14: North America Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 15: North America Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 16: North America Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 17: North America Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 18: North America Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 19: North America Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 20: North America Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 21: North America Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 22: North America Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 23: United States Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 24: United States Losartan Market Size, By Source, 2016-2026F
Figure 25: United States Losartan Market Size, By Form, 2016-2026F
Figure 26: United States Losartan Market Size, By Strength, 2016-2026F
Figure 27: United States Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 28: United States Losartan Market Share, By Application, 2016-2026F
Figure 29: United States Losartan Market Share, By End-User, 2016-2026F
Figure 30: Canada Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 31: Canada Losartan Market Size, By Source, 2016-2026F
Figure 32: Canada Losartan Market Size, By Form, 2016-2026F
Figure 33: Canada Losartan Market Size, By Strength, 2016-2026F
Figure 34: Canada Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 35: Canada Losartan Market Share, By Application, 2016-2026F
Figure 36: Canada Losartan Market Share, By End-User, 2016-2026F
Figure 37: Mexico Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 38: Mexico Losartan Market Size, By Source, 2016-2026F
Figure 39: Mexico Losartan Market Size, By Form, 2016-2026F
Figure 40: Mexico Losartan Market Size, By Strength, 2016-2026F
Figure 41: Mexico Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 42: Mexico Losartan Market Share, By Application, 2016-2026F
Figure 43: Mexico Losartan Market Share, By End-User, 2016-2026F
Figure 44: Europe Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 45: Europe Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 46: Europe Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 47: Europe Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 48: Europe Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 49: Europe Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 50: Europe Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 51: Europe Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 52: Europe Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 53: Europe Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 54: Germany Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 55: Germany Losartan Market Size, By Source, 2016-2026F
Figure 56: Germany Losartan Market Size, By Form, 2016-2026F
Figure 57: Germany Losartan Market Size, By Strength, 2016-2026F
Figure 58: Germany Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 59: Germany Losartan Market Share, By Application, 2016-2026F
Figure 60: Germany Losartan Market Share, By End-User, 2016-2026F
Figure 61: France Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 62: France Losartan Market Size, By Source, 2016-2026F
Figure 63: France Losartan Market Size, By Form, 2016-2026F
Figure 64: France Losartan Market Size, By Strength, 2016-2026F
Figure 65: France Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 66: France Losartan Market Share, By Application, 2016-2026F
Figure 67: France Losartan Market Share, By End-User, 2016-2026F
Figure 68: United Kingdom Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 69: United Kingdom Losartan Market Size, By Source, 2016-2026F
Figure 70: United Kingdom Losartan Market Size, By Form, 2016-2026F
Figure 71: United Kingdom Losartan Market Size, By Strength, 2016-2026F
Figure 72: United Kingdom Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 73: United Kingdom Losartan Market Share, By Application, 2016-2026F
Figure 74: United Kingdom Losartan Market Share, By End-User, 2016-2026F
Figure 75: Italy Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 76: Italy Losartan Market Size, By Source, 2016-2026F
Figure 77: Italy Losartan Market Size, By Form, 2016-2026F
Figure 78: Italy Losartan Market Size, By Strength, 2016-2026F
Figure 79: Italy Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 80: Italy Losartan Market Share, By Application, 2016-2026F
Figure 81: Italy Losartan Market Share, By End-User, 2016-2026F
Figure 82: Spain Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 83: Spain Losartan Market Size, By Source, 2016-2026F
Figure 84: Spain Losartan Market Size, By Form, 2016-2026F
Figure 85: Spain Losartan Market Size, By Strength, 2016-2026F
Figure 86: Spain Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 87: Spain Losartan Market Share, By Application, 2016-2026F
Figure 88: Spain Losartan Market Share, By End-User, 2016-2026F
Figure 89: Russia Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 90: Russia Losartan Market Size, By Source, 2016-2026F
Figure 91: Russia Losartan Market Size, By Form, 2016-2026F
Figure 92: Russia Losartan Market Size, By Strength, 2016-2026F
Figure 93: Russia Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 94: Russia Losartan Market Share, By Application, 2016-2026F
Figure 95: Russia Losartan Market Share, By End-User, 2016-2026F
Figure 96: Poland Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 97: Poland Losartan Market Size, By Source, 2016-2026F
Figure 98: Poland Losartan Market Size, By Form, 2016-2026F
Figure 99: Poland Losartan Market Size, By Strength, 2016-2026F
Figure 100: Poland Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 101: Poland Losartan Market Share, By Application, 2016-2026F
Figure 102: Poland Losartan Market Share, By End-User, 2016-2026F
Figure 103: Asia-Pacific Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 104: Asia-Pacific Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 105: Asia-Pacific Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 106: Asia-Pacific Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 107: Asia-Pacific Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 108: Asia-Pacific Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 109: Asia-Pacific Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 110: Asia-Pacific Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 111: Asia-Pacific Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 112: Asia-Pacific Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 113: China Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 114: China Losartan Market Size, By Source, 2016-2026F
Figure 115: China Losartan Market Size, By Form, 2016-2026F
Figure 116: China Losartan Market Size, By Strength, 2016-2026F
Figure 117: China Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 118: China Losartan Market Share, By Application, 2016-2026F
Figure 119: China Losartan Market Share, By End-User, 2016-2026F
Figure 120: Japan Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 121: Japan Losartan Market Size, By Source, 2016-2026F
Figure 122: Japan Losartan Market Size, By Form, 2016-2026F
Figure 123: Japan Losartan Market Size, By Strength, 2016-2026F
Figure 124: Japan Losart
